These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of sexual symptoms in relation to menopause in women in Asia: a systematic review. Islam RM; Bell RJ; Davis SR Menopause; 2018 Feb; 25(2):231-238. PubMed ID: 28858028 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of menopausal symptoms in Asian midlife women: a systematic review. Islam MR; Gartoulla P; Bell RJ; Fradkin P; Davis SR Climacteric; 2015 Apr; 18(2):157-76. PubMed ID: 24978151 [TBL] [Abstract][Full Text] [Related]
6. Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens - Cluster analysis of a web-based Italian survey among women over 40. Nappi RE; Di Carlo C; Cucinella L; Gambacciani M Maturitas; 2020 Oct; 140():72-79. PubMed ID: 32616374 [TBL] [Abstract][Full Text] [Related]
7. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study. Zeleke BM; Bell RJ; Billah B; Davis SR Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529 [TBL] [Abstract][Full Text] [Related]
8. Urogenital effects of the menopause. Schaffer J; Fantl JA Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):401-17. PubMed ID: 8931902 [No Abstract] [Full Text] [Related]
9. The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review. Rueda C; Osorio AM; Avellaneda AC; Pinzón CE; Restrepo OI Climacteric; 2017 Aug; 20(4):321-330. PubMed ID: 28622049 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Stenberg A; Heimer G; Ulmsten U; Cnattingius S Maturitas; 1996 May; 24(1-2):31-6. PubMed ID: 8794431 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of menopausal symptoms--review of the current literature]. Magyar Z; Fél T Orv Hetil; 2006 May; 147(19):879-85. PubMed ID: 16784143 [TBL] [Abstract][Full Text] [Related]
12. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Erekson EA; Li FY; Martin DK; Fried TR Menopause; 2016 Apr; 23(4):368-75. PubMed ID: 26645820 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of menopausal symptoms in Australian women at midlife: a systematic review. Gartoulla P; Islam MR; Bell RJ; Davis SR Climacteric; 2014 Oct; 17(5):529-39. PubMed ID: 24245562 [TBL] [Abstract][Full Text] [Related]
14. Urogenital atrophy: diagnosis, sequelae, and management. Keil K Curr Womens Health Rep; 2002 Aug; 2(4):305-11. PubMed ID: 12150759 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Cardozo L; Bachmann G; McClish D; Fonda D; Birgerson L Obstet Gynecol; 1998 Oct; 92(4 Pt 2):722-7. PubMed ID: 9764689 [TBL] [Abstract][Full Text] [Related]
17. The management of lower urogenital changes in the menopause. Singh S; van Herwijnen I; Phillips C Menopause Int; 2013 Jun; 19(2):77-81. PubMed ID: 23778562 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of urogenital symptoms in postmenopausal women. Stenberg A; Heimer G; Ulmsten U Maturitas; 1995 Dec; 22 Suppl():S17-S20. PubMed ID: 8775772 [TBL] [Abstract][Full Text] [Related]
19. [Urogenital complaints: value of systemic estrogen therapy]. Hänggi W; Dörflinger A Praxis (Bern 1994); 1997 Aug; 86(33):1260-3. PubMed ID: 9381012 [TBL] [Abstract][Full Text] [Related]
20. Vasomotor symptoms in women in Asia appear comparable with women in Western countries: a systematic review. Islam RM; Bell RJ; Rizvi F; Davis SR Menopause; 2017 Nov; 24(11):1313-1322. PubMed ID: 28640160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]